FDA Urged to Protect Patients from Payer-Mandated Drug Distribution Model

March 31, 2021

The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”

Under the white bagging model, payers require patients to receive their medications through a narrow network of specialty pharmacies often affiliated with the payer, and providers to hold the medications until the patient arrives for treatment. 

View the entire letter under Key Resources.